Amyris Closes Acquisition Of Beauty Labs Combining Synthetic Biology Leadership With Digital Innovation
Amyris, Inc. a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, announced that, on August 31, it closed the acquisition of Beauty Labs International Ltd. (“Beauty Labs”), a leader in AI technology that provides breakthrough connected consumer experiences to the beauty and wellness community.
Amyris is accelerating its growth and market leadership in clean beauty by adding digital innovation, machine learning and data science to further enhance the consumer experience of its family of consumer brands consisting of Biossanceâ, Pipetteâ, Terasanaâ, Costa Brazil, OLIKA, Rose Inc. ™and JVN™, These Amyris brands will leverage Beauty Labs’ leading AI technology to create compelling, personalized, connected consumer experiences and further accelerate the growth of Amyris’ ecommerce revenue.
Beauty Labs is a data sciences and machine learning technology company that has developed one of the leading consumer applications for “try before you buy” color cosmetics. This technology applies the power of machine learning and AI technology to match color cosmetics products with skin tone. Beauty Labs is also developing advanced software that assesses skin conditions to make product recommendations to improve skin health, along with a user interface to track acne and other skin conditions so that consumers can fully benefit from the suite of Amyris’ leading clean beauty and skin treatment offerings.
Recommended AI News: Qualifio Appoints Quentin Paquot As New CEO
Amyris has already commenced the integration of the Beauty Labs technology into its direct-to-consumer websites with promising early results on the Rose Inc. direct-to-consumer channel of a higher conversion to purchase for consumers using the color matching technology. Beauty Labs and MG Empower, the influencer marketing and digital innovation partner acquired by Amyris last month, represent critical components of Amyris’ strategy of deepening the beauty consumer relationship and delivering the best digital retail beauty experience. These technologies deepen the consumer experience of Amyris’ unique portfolio connection from the creation of differentiated sustainable ingredients by its Lab-to-Market™ science and technology to the formulation into consumer products that are better for people and the planet. Amyris’ path to manufacturing at scale and to commercializing ingredients outpaces its peer group in synthetic biology. Squalane, Hemisqualane, Biosilica and CBG, Amyris ingredients that are naturally produced from clean fermentation, differentiate consumer-oriented products and deliver significant revenue growth. The bridge between ingredients, clean beauty products and ecommerce technologies evidence the power of Amyris’ vertically integrated business model and its deep connection with the consumer.
“We are delivering the fastest revenue growth of any synthetic biology platform in the world and generate more total revenue than the aggregate of our immediate peers,” commented John Melo, President and Chief Executive Officer of Amyris. “We are advancing our leadership position by deepening the relationship with consumers to enable us to deliver more value while increasing our share of wallet through our direct-to-consumer business. Influencers are increasingly becoming the direct sellers of product through their platforms and we want to lead this transition with data science. We are already benefiting from these strategic moves and are on track to deliver our best quarter in consumer revenue by far.”